The Coalition for Health AI’s board of directors has recently welcomed two new members, Micky Tripathi and Troy Tazbaz. Tripathi is the national coordinator for health information technology and acting chief AI officer at the Department of Health and Human Services (HHS), while Tazbaz is the director of the Digital Health Center of Excellence at the Food and Drug Administration (FDA). Their roles in government bring a fresh perspective to the group’s mission to set safety standards and frameworks for evaluating artificial intelligence models in healthcare.
However, just four months after joining the board, Tripathi and Tazbaz have decided to step down due to potential conflicts of interest arising from their roles in the federal government. In a statement to STAT, Tripathi mentioned that his various roles across HHS could create conflicts, prompting their decision to withdraw from the industry body. He also leads HHS’ AI task force, which was established as part of a White House executive order on safe AI use. The FDA did not provide a comment on the situation.
This move highlights the complex relationship between government officials and private industry when it comes to regulating emerging technologies like artificial intelligence in healthcare. It also underscores the importance of addressing potential conflicts of interest to ensure transparency and accountability in setting guidelines for AI use in the medical field.
The Coalition for Health AI aims to promote responsible development and deployment of AI models in healthcare by providing guidance on ethical considerations, data privacy, security, transparency, accountability, fairness, bias mitigation strategies and other related issues.
The departure of Tripathi and Tazbaz may leave a void in their expertise but it also opens up an opportunity for new perspectives on how to navigate these complex issues.
As technology continues to advance rapidly in this field, it is crucial that we have robust frameworks in place that balance innovation with safety standards. With strong leadership from both public and private sectors working together towards this goal, we can ensure that patients receive high-quality care while minimizing risks associated with emerging technologies like AI.